Indonesia vs Sub-Saharan Africa: Percentage of bloodstream infection due to Escherichia coli resistant
Indonesia
69.7%
in 2022
Sub-Saharan Africa
70.6%
in 2022
Indonesia rank
8th
Sub-Saharan Africa rank
5th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Indonesia
- Sub-Saharan Africa
How they compare
Sub-Saharan Africa currently reports 70.6% against 69.7% in Indonesia, a difference of 0.9%.
The two have swapped places 1 time across 5 shared years of data; in 2018 it was Indonesia ahead.
Indonesia ranks 8th and Sub-Saharan Africa ranks 5th of 50 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Sub-Saharan Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.0% | 52.5% | 18.5% | Indonesia |
| 2020s | 72.2% | 70.2% | 1.9% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Indonesia or Sub-Saharan Africa?
- Sub-Saharan Africa, at 70.6% against 69.7% in Indonesia as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Indonesia and Sub-Saharan Africa?
- 0.9%, with Sub-Saharan Africa ahead.
- How many years of comparable data are there for Indonesia and Sub-Saharan Africa?
- 5 years are reported by both, from 2018 to 2022.
- How do Indonesia and Sub-Saharan Africa rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Indonesia ranks 8th and Sub-Saharan Africa ranks 5th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.